Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Down 42.5% in November

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) was the target of a significant drop in short interest during the month of November. As of November 15th, there was short interest totalling 21,400 shares, a drop of 42.5% from the October 31st total of 37,200 shares. Based on an average daily volume of 77,100 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.3% of the company’s shares are short sold.

Sol-Gel Technologies Trading Down 2.4 %

Shares of Sol-Gel Technologies stock traded down $0.01 on Friday, hitting $0.56. 43,222 shares of the company traded hands, compared to its average volume of 138,136. The company has a market cap of $15.63 million, a PE ratio of -1.65 and a beta of 1.60. The stock’s 50 day moving average price is $0.61 and its 200-day moving average price is $0.67. Sol-Gel Technologies has a 52 week low of $0.33 and a 52 week high of $1.58.

Analyst Ratings Changes

Separately, Raymond James cut shares of Sol-Gel Technologies from a “strong-buy” rating to an “outperform” rating and cut their price target for the stock from $6.00 to $4.00 in a report on Monday, August 19th.

About Sol-Gel Technologies

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.